Inventaire - your friends and communities are your best library

Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization

published in: Journal of Virology

date of publication: 1994-09-01

language: English

main subject: antibody

Cites articles 43

Date

Title

Authors

1993-06-01

A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism
1993-03-01

Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans
1993-01-01

Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination
1993-08-27

Genotypic and phenotypic characterization of HIV-1 patients with primary infection
1993-10-01

Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1.
1993-02-01

Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans
1993-10

Costimulatory properties of the human CD4 molecule: enhancement of CD3-induced T cell activation by human immunodeficiency virus type 1 through viral envelope glycoprotein gp120
1993-12-01

V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1
1993-01-01

Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization
1993-11-01

Jitters jeopardize AIDS vaccine trials
1992-03-01

Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population

Neeltje A Kootstra
1992-02-01

Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity
1992-01-01

The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism
1992-01-01

Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates
1992-05-01

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

Neeltje A Kootstra
1992-12-01

Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody

Anthony J. Conley
1992-11-01

Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution
1992-11-01

Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism
1992-09-01

Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity
1992-05-01

Mapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4
1992-01-01

Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins

Kristina Broliden, Eva Maria Fenyö
1992-02-01

Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120
1992-11-01

Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates,Monoclonal Antibodies to the Extracellular Domain of HIV-1IIIB gp160 that Neutralize Infectivity, Block Binding to CD4, and React with Diverse Isolates
1992-01-01

Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies

Maiken C Arendrup
1992-01-01

HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay

Roel Coutinho, René Keet
1992-03-01

Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection

Roel Coutinho
1992-07-01

Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype

René Keet
1991-07-01

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1

Herbert Kim Lyerly
1991-11-01

Isolate-specific neutralizing antibodies in patients with progressive HIV-1-related disease

Kristina Broliden, Eva Maria Fenyö
1991-07-01

Immunological and virological markers in individuals progressing from seroconversion to AIDS.
1991-06-01

Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus
1990-10-01

Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation

Article - wd:Q36635390

Welcome to Inventaire

the library of your friends and communities

learn more